Introduction
============

Enzootic bovine leukosis (EBL) is the most important type of bovine lymphotropic retrovirus infection, and this disease is caused by bovine leukemia virus (BLV).^[@bib1],\ [@bib2]^ According to the International Committee for Taxonomy of Viruses classification scheme, BLV is a deltaretrovirus genus of the retroviridae family.^[@bib3]^ BLV has many structural and functional characteristics common with human T-lymphotropic viruses.^[@bib4]^ BLV causes chronic infection in cattle and develops into three possible pathological forms. Most BLV-infected animals appear asymptomatic (clinically healthy).^[@bib5]^ Approximately one-third of infected animals develop persistent lymphocytosis (PL) due to polyclonal proliferation of B lymphocytes, and 0.1%--10% develop lymphoid tumors, primarily B-cell lymphosarcomas.^[@bib6],\ [@bib7]^

BLV affects the health of infected animals and impacts the beef and dairy industries.^[@bib8]^ BLV infects approximately one-third of the adult dairy cattle in the United States, and is a major cause of the loss of export markets for breeding cattle.^[@bib9]^ Direct economic losses are incurred because of death, decreases in milk productivity, fertility and life span, and condemnation at slaughter.^[@bib8],\ [@bib10]^

BLV is widespread in populations of cattle worldwide, and infection remains endemic in many countries.^[@bib11]^ BLV has high prevalence in South America, some Asiatic and Middle Eastern countries, and Eastern Europe.^[@bib12],\ [@bib13],\ [@bib14],\ [@bib15]^

The most important source of BLV transmission from infected cattle is via blood lymphocytes and other tissue products.^[@bib16]^ Close contact transmission, hematophagous flies and iatrogenic transfer through the use of contaminated veterinary instruments are all well-documented sources of BLV transmission between infected and non-infected cattle.^[@bib17],\ [@bib18],\ [@bib19]^ Although in utero transmission of BLV from a cow to its fetus can occur, it is relatively rare.^[@bib20]^ Colostrum, milk-borne and artificial insemination BLV transmission have also been reported.^[@bib20],\ [@bib21],\ [@bib22]^

Agar gel immunodiffusion is the prescribed diagnostic test for international trade and the most common method used to detect BLV-specific antibodies. Several enzyme-linked immunosorbent assays (ELISA) are also available to diagnose BLV.^[@bib23],\ [@bib24]^ Agar gel immunodiffusion is as sensitive as the routinely used indirect ELISA test; it is highly specific, reliable and easy to perform.^[@bib25]^ PCR has also been described as a diagnostic test.^[@bib26]^ PCR is a useful method to detect recently infected animals before seroconversion. It can also be used to confirm neonatal BLV infection because serological tests cannot differentiate between antibodies produced *de novo* in response to infection and those that are transferred passively in colostrum.^[@bib27],\ [@bib28]^

The prevalence of BLV worldwide varies widely between countries; prevalence has been found to be as low as 5% in Cambodia and Taiwan^[@bib19]^ and 17% in Turkey^[@bib29]^ or as high as 83.9% in the US and 25.7% in Canada.^[@bib30],\ [@bib31]^ Although BLV impacts the Iraqi economy because it is neglected in Iraq, this study sought to identify a comprehensive molecular and seroepidemiological screening for infected animals to establish a provision for disease control and eradication.

Materials and methods
=====================

Ethics statement
----------------

The Baghdad University College of Veterinary Medicine Review Board and Institutional Review Board of the Iraqi Center for Cancer and Medical Genetic research approved this study. Consent was obtained from the farm owners before animal sampling.

Animals
-------

The animals examined were dairy cattle raised on private dairy farms located in two governorates, Al Qadisiyah and Al Mouthanna, as well as animals of one station dairy. A total of 400 cross-breed cattle (Friesian with native cattle) and local-breed cattle (native cattle) were investigated. The samples were divided into 227, 78 and 95 cattle from the Al Qadisiyah, Al Mouthanna and station dairy herds, respectively. The cattle were older than six months and were selected based on clinical signs indicating that they may had BLV. The cattle were divided into two age groups: ⩾two years old and \<two years old. The study began in March 2014 and was completed in December 2015.

Sample collection
-----------------

Registered veterinarians obtained peripheral blood aseptically from the jugular vein with and without anticoagulant using a vacutainer system in two sterile vacuum tubes. The samples were then refrigerated and stored until they arrived at the laboratory.

Hematological examination
-------------------------

Fresh peripheral blood samples were used for total leukocyte and differential leukocyte counts, and obtained by standard veterinary procedures.^[@bib32]^ The leukocyte count was performed manually using a hemocytometer counting chamber to determine the number of leukocytes per 1 μL of blood. The differential leukocyte count was performed using a thin blood smear stained with a Diff-Quik stain kit (Syrbio, Switzerland), and a count of 200 atypical leukocytes was considered as being a positive case.

Serum preparation and serological test
--------------------------------------

The blood samples were centrifuged for 10 min at 2000 rpm, and then, serum was collected in 1.5 mL Eppendorf tubes and stored at −80 °C until further analysis. All 400 serum samples were tested for BLV using a Svanovir BLV-gp51-Ab ELISA test kit (Svanova Biotech AB, Uppsala, Sweden). The procedures were performed according to the manufacturer\'s instructions.

Polymerase chain reaction (PCR)
-------------------------------

Genomic DNA was extracted from peripheral blood mononuclear cells (PBMCs) after isolation from whole blood using the Histopaque 1077 density gradient technique (Sigma-Aldrich, Steinheim, Germany). DNA extraction was performed using a Magnesia Genomic DNA Whole Blood Kit and Magnesia Automated DNA Extraction machine (Anatolia Geneworks, İstanbul, Turkey). All DNA extraction steps were performed according to the manufacturer\'s instructions. The extracted DNA samples were quantified and stored at −86 °C until used.

The extracted DNA samples were used as a template to detect BLV proviral DNA by single PCR using two sets of primers, a pol1 primer set and an env1 primer set. In the pol1 primer, the forward primer was 5′-CGG GAT TGA TCA CCC CGG AA-3 (546--565), and the reverse primer was 5′-GGA CTC CGT CGG GAA GGT T-3 (1033--1052). These were based on conserved regions of the 3′ end of the *pol* gene using an online program (OligoAnalyzer 3.1, Integrated DNA Technologies, Inc., Coralville, IA, USA) to amplify a 507-bp fragment.

The reaction final volume was 25 μL, which consisted of 12.5 μL KAPA2G of Robust HotStart ReadyMix 1 × (Kapa Biosystems, Cape Town, South Africa) containing 0.2 mM/L of each dNTP, 3 mM/L of MgCl~2~, 1 unit of Robust HotStart DNA polymerase, 1.5 μL (0.6 μM) of each primer, 4 μL of the extracted DNA samples and 5.5 μL of PCR-grade water. Using a SureCycler 8800 Thermo Cycler (Agilent technologies, Santa Clara, CA, USA), the theromocycling conditions were as follows: initial denaturation at 95 °C for 5 min, followed by 35 cycles of denaturation at 95 °C for 20 s, annealing at 61 °C for 20 s and extension at 69 °C for 1 min, with a final extension at 69 °C for 3 min. The second primer set for the *env1* gene was based on previous publications.^[@bib33],\ [@bib34]^ In the *env1* set, the forward primer was 5-CCC ACA AGG GCG GCG CCG GTT T-3 (5099--5120), and the reverse primer 5-GCG AGG CCG CGT CCA GAG CTG G-3 (5521--5542). The PCR mixture (25 μL) consisted of 12.5 μL of 1 μ polymerase buffer, 2 mM MgCl~2~, 0.2 of each mM dNTP, 1 μL of 0.5 mM of each primer, 4 μL of 0.5 mg of DNA and 7.5 μL of PCR-grade water. Amplification conditions started with initial denaturation at 94 °C for 3 min, followed by 35 cycles of denaturation at 94 °C for 1 min, primer annealing at 65 °C for 20 s and elongation at 72 °C for 30 s. The final elongation of amplification was 5 min.

The final amplified products were detected by electrophoresis through a 1% agarose gel containing ethidium bromide in Tris/Borate/EDTA buffer (90 mM Tris-borate and 2 mM EDTA). DNA was visualized using VISION Gel Documentation (Scie-Plas, Cambridge, UK).

Results
=======

Clinical findings
-----------------

Most BLV-infected cattle were clinically asymptomatic during examination and exhibited only nonspecific findings, such as emaciation, rough hair coat and pale mucus membrane.

Hematological findings
----------------------

According to cattle age, an absolute lymphocyte count of more than 8000 lymphocytes/μL was diagnosed as leukemic leukosis (persistent lymphocytosis: PL). Of the 31 BLV-positive cattle, the total leukocyte counts of five animals (29.0%) were 16 950, 10 900, 15 000, 29 250 and 15 950 lymphocytes/μL. The absolute lymphocytes count for these samples were 8390, 8271, 9636, 21 090 and 10 148 lymphocytes/μL, respectively; thus, PL was diagnosed. Based on the European hematological diagnostic guidelines ([Table 1](#tbl1){ref-type="table"}) one sample with a serological reaction had neutrophilia with increased band cells, whereas the remaining samples (22 of 31; 70.9%) were within normal limits. A small number of atypical lymphocytes were observed in the some BLV-positive cattle. No hematologic evidence of bovine leukosis was observed in the BLV-negative cattle, but cattle samples with leukocytosis with lymphocytosis or neutrophilia and whose serological and molecular results were negative were excluded. Leukosis in these animals might have been due to other diseases, such as blood parasites (theileriosis and anaplasmosis), which had appeared in the blood smears of some of these cattle.

Serum antibodies against BLV were detected in 28 (7%) of the 400 samples. The seroprevalence rates of BLV in the three location areas were 8.8% for the Al Qadisiyah herd, 2.6% for the Al Mouthanna herd and 6.3% for the station dairy herd ([Table 2](#tbl2){ref-type="table"}). These sample locations were significantly different (*P*=0.01) (χ^2^ test).

The serum samples exhibited varying degrees of reactivity in the ELISA; of the 28 seropositive samples, seven exhibited a strong positive reaction, and the remaining 21 samples reacted weakly.

Polymerase chain reaction (PCR)
-------------------------------

Using two sets of specific BLV primers, the PCR results confirmed the BLV serological results. Of the 400 examined DNA samples, 31 (7.75%) were as positive, and all seropositive samples that underwent PCR analysis tested positive for both primer sets. In addition, the three (0.8%) samples seronegative with ELISA were positive using PCR ([Table 3](#tbl3){ref-type="table"}). The PCR results confirmed the presence of 444-bp and 507-bp fragments of the *pol1* and *env1* genes, which were amplified to the standard ladder bands ([Figure 1](#fig1){ref-type="fig"}).

The epidemiological results are summarized in [Table 4](#tbl4){ref-type="table"}. The highest percentage (8.3%) of infection was observed among the local breed of cattle (five animals); in the cross-breed cattle, the percentage of infection (7.6%) was slightly lower (26 animals) (*P*⩽0.05). Among the two age groups, only two of the 70 cattle in the \<two years old group were positive, whereas 29 of the 330 cattle (8.8%) in the ⩾two years-old-age group were positive; this difference was significant (*P*⩾0.05). The females exhibited a higher percentage of infection (7.34% 29 animals) compared with males (4.34%, two animals).

Discussion
==========

This study is the first in the middle Euphrates region in Iraq to confirm the presence of BLV in all cattle breeds and to describe its epidemiology. The percentage of BLV infection was 7.75% in the Iraqi cattle examined here, as measured by PCR. In neighboring countries, the percentage of BLV infection is 17% in Iran,^[@bib35]^ 11% in Turkey^[@bib36]^ and Jordon.^[@bib37]^ The present study demonstrated that the percentage of BLV infection in Iraqi cattle is lower than other countries, such as Korea (35%),^[@bib38]^ Tanzania (36%),^[@bib39]^ China (21.24%)^[@bib40]^ and Thailand (32.5%),^[@bib41]^ whereas the percentage in Iraq was higher than the 3.67% reported in some parts of Turkey.^[@bib42]^ Differences in the percentage of BLV infection are likely to occur between countries and locations within the same country.

A previous serological study in Baghdad, Iraq, reported BLV infection frequency very similar to that reported here (7%).^[@bib43]^ The prevalence of infection observed here does not necessarily represent the actual prevalence of BLV infection in the studied areas because most samples were not randomly collected; instead, they were selected based on clinical signs that might indicate that the animal most likely infected with BLV.

The low occurrence of infection among Iraqi cattle might be related to certain conditions and management practices in the dairies investigated here because herd size has an important role in BLV prevalence.^[@bib44]^ High prevalence of BLV in cattle is mostly related to high-density cattle populations and poor sanitation conditions; close physical contact and contaminated biological materials appear to be required for BLV transmission.^[@bib45]^

Recent studies have shown that BLV sequences, which can be classified into seven distinct genotypes, are circulating in cattle from the US and South America.^[@bib46]^ Weak reactions using ELISA indicated a high percentage (67.8%) of seropositive samples, and most weak reactivity is likely due to the variable specificity of the serum antibodies or the presence of preexisting low levels of antibodies due to a latent natural infection in these animals.^[@bib47]^ The low reactivity could also be because the serum antibodies possess low-affinity constants, which can lead to dissociation of the antigen--antibody complex during the multiple washing steps of the assay and consequently result in a weak positive reactivity in some cases. In addition, the probability of different antigenic strains of BLV with relative immunogenicity is characteristic of weak reaction using serological tests.^[@bib48]^

Serological tests have been used more extensively to identify BLV-infected cattle worldwide due to their rapidity, cost-effectiveness and easy interpretation.^[@bib46]^ BLV status conversion is detected via PCR assay more rapidly than via ELISA in recent infections, before the development of antibodies, in doubtful reactions, and weak positive reactions in ELISA.^[@bib26]^ Thus, PCR amplification was used to examine seropositive cattle and seronegative cattle for the presence of BLV provirus in PBMCs.

The provirus integration of BLV has been investigated in PBMCs isolated from cattle blood.^[@bib49]^ In the present study, PCR use in the preliminary field screen further demonstrated the advantages of PCR as a BLV detection technique. PCR was performed based on primer sites within conserved regions of the *pol* and *env* genes that flank a region of variability. We hypothesized that by basing the primer design on the conserved regions, the assay would be able to detect a variety of serologically different BLV strains.^[@bib50]^ BLV infection in cattle results in a strong permanent antibody response to the BLV antigens weeks after infection, and some infected cattle may carry the provirus and not have detectable antibody titers.^[@bib32]^ All serologically positive samples and the three negative samples were positive using PCR; thus, our results are in close agreement to those reported in Brandon *et al.*,^[@bib51]^ which noted that the sensitivity of PCR permitted the detection of bovine leukemia provirus in 6.8% of serologically negative BLV-exposed cattle.

Leukocyte counts in some of the BLV-infected cows were significantly higher due to significantly higher lymphocyte counts, which has also been described in a study that found 8800 (56%) to 9595 (67.5%) of the BLV-infected cows had PL.^[@bib52]^

Weight loss, poor hair coat and weakness are the clinical signs most commonly associated with BLV infection in cattle. In the present study, these abnormal clinical signs were recorded during the animal examination and sample collection, and our findings were similar to observations by others.^[@bib52]^

The present study also demonstrated an association between age and BLV infection. Infection most commonly occurred in animals \>two years old, and the incidence of infection increased with age based on virus detection in colostrum and milk, suggesting a role of both colostrum and milk in disease transmission.^[@bib52],\ [@bib53]^ The higher prevalence of BLV in older animals could be caused by several different factors. When animals are housed in the same free-stall barns, close contact among animals could increase transmission. As a cow ages, the likelihood of sufficient contact with an infected animal and transmission of the infection from infected herd mates increases. In addition, older animals are more susceptible to infections.^[@bib4]^ These results were similar to those of other studies.^[@bib35],\ [@bib51]^ The present study provides evidence that BLV infection in Iraqi cattle is endemic. More attention to this disease is required to establish effective prevention and control measures. A comprehensive screening of all animals should be conducted on all Iraq cattle farms. The programs to segregate infected animals and eliminate transmission can be effective and particularly important for controlling the spread of BLV because no effective vaccines are available.^[@bib54],\ [@bib55]^

![Ethidium bromide-stained agarose gel electrophoresis of the PCR product of BLV. (**A**) Loading 15 μL of the amplification resulted in the predicted 507-bp amplification product of the *pol* gene of the BLV provirus through 1% agarose stained with ethidium bromide. (**B**) PCR product of BLV (444-bp fragment of the *env* gene) in positive PBMCs isolated from the blood samples. Bovine leukemia virus, BLV; peripheral blood mononuclear cells, PBMCs; polymerase chain reaction, PCR.](emi201660f1){#fig1}

###### Summary of the BLV-positive samples with the three methods

  **Cattle sample**   **Sex**    **Age (years)**   **WBC (μL)**      **Lymphocyte (μL)**       **Hematology**   **ELISA**   **PCR**
  ------------------- --------- ----------------- -------------- ---------------------------- ---------------- ----------- ---------
  3                   F                 6             16950                  8390                    PL            \+         \+
  7                   F                 7             11650                  6638                    AL            \+         \+
  16                  F                 9             10900                  8271                    PL            \+         \+
  29                  F                 8             11900                  6188                    AL            \+         \+
  43                  F                10              8500                  6946                    AL            \+         \+
  66                  F                 6             22000                  7946                    AL             −         \+
  76                  F                 7             11750                  4582                    AL            \+         \+
  80                  F                 8             19550                  5980                    AL            \+         \+
  82                  F                 6             12850                  5810                    AL            \+         \+
  103                 F                 8              7600                  3990                    AL            \+         \+
  135                 M                2.5            22850                 10800                    AL            \+         \+
  139                 F                 7             10250                  7412                    AL            \+         \+
  152                 F                 7              7500                  4010                    AL            \+         \+
  158                 F                12             15750                  6636                    AL             −         \+
  162                 F                 8             15000                  9675                    PL            \+         \+
  166                 F                12              4250                  2016                    AL            \+         \+
  170                 F                1.5             8200                  3840                    AL            \+         \+
  181                 F                 8              5950                  3098                    AL            \+         \+
  194                 F                 7              9850                  4688                    AL            \+         \+
  200                 F                10              5426                  1899                    AL            \+         \+
  228                 F                 7             61750       5372/ (41002 neutrophilia)    Neutrophilia       \+         \+
  253                 F                 2              8200                  5125                    AL             −         \+
  257                 F                 5             29250                 21090                    PL            \+         \+
  279                 F                 4             24700                  7113                    AL            \+         \+
  297                 F                 5             12950                  6410                    AL            \+         \+
  299                 F                 4             16400                  4740                    AL            \+         \+
  303                 M                 4             13150                  6910                    AL            \+         \+
  331                 F                16              3800                  844                     AL            \+         \+
  340                 F                 7              6800                  4420                    AL            \+         \+
  364                 F                10             11600                  5498                    AL            \+         \+
  374                 F                 8             15950                 10148                    PL            \+         \+

Abbreviations: persistent lymphocytosis, PL; aleukemic leukemia, AL.

###### Distribution of seropositive cattle in the sampled study areas

  **City**        **Infected**  **Non-infected**   **Total**
  -------------- -------------- ------------------ -----------
  Al Qadisiyah     20 (8.8%)    205                225
  Al Mouthanna      2 (2.6%)    76                 78
  Station herd      6 (6.3%)    91                 97
  Total             28 (7%)     372                400

###### BLV infectivity percentages by ELISA and PCR examination of 400 cattle samples

  **Test**   **PCR+**    **PCR−**    **Total**
  ---------- ----------- ---------- -----------
  ELISA+     28 (7%)     0            28 (7%)
  ELISA−     3 (0.75%)   369            372
  Total      31(7.75%)   369            400

###### Identification of BLV infection according to breed, age and sex

                **Cattle breed**   **Age**     **Sex**                                                                  
  ------------ ------------------ ---------- ------------ ----------- ----------- ------------ ----------- ------------ ------------
  Infected         26 (7.6%)       5 (8.3%)   31 (7.75%)   2 (2.85%)   29 (8.8%)   31 (7.75%)   2 (4.34%)   29 (7.34%)   31 (7.75%)
  Uninfected          314             55         369          68          301         869          44          325          369
  Total               340             60         400          70          330         400          46          354          400
